LoLa Capital Partners
Funding rounds backed by LoLa Capital Partners.
- Funding disclosed in full
- $263M
- Median round
- $263M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| LifeMine Therapeutics Develops fungal genome-derived therapeutics for organ transplant rejection | $263MSeries D+Series E | BiotechUnited States |